Reintroduction regimens in anti-tubercular therapy-induced hepatitis in extra-pulmonary tuberculosis patients - A pilot study

The recurrence rate of hepatotoxicity was statistically insignificant between the three groups (p > 0.05), and thus all three hepatotoxic drugs can be reintroduced safely in patients developing AIH.